Morpholine → HCID 45376602, compound
Reaction equation
[NH2:1][C:2]1[C:10]2[C:5](=[N:6][C:7]([CH3:16])=[C:8]([O:12][CH2:13][CH2:14]Cl)[C:9]=2[CH3:11])[S:4][C:3]=1[C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18].C([O-])([O-])=O.[K+].[K+].[NH:30]1[CH2:35][CH2:34][O:33][CH2:32][CH2:31]1>CC#N>[NH2:1][C:2]1[C:10]2[C:5](=[N:6][C:7]([CH3:16])=[C:8]([O:12][CH2:13][CH2:14][N:30]3[CH2:35][CH2:34][O:33][CH2:32][CH2:31]3)[C:9]=2[CH3:11])[S:4][C:3]=1[C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
tert-Butyl 3-amino-5-(2-chloroethoxy)-4,6-dimethyl-thieno[2,3-b]pyridine-2-carboxylate, prepared above (50 mg, 0.22 mmol), was dissolved in CH3CN (5 mL), followed by the addition of K2CO3 (41 mg, 0.30 mmol), morpholine (26 mg, 0.30 mmol) and a catalytic amount of KI. The mixture was heated to reflux overnight, the solvent was removed under reduced pressure, water was added and the residue was extracted with ethyl acetate (10 mL), and the organic phases were washed with water (5 mL×3), brine, dried over anhydrous Na2SO4, concentrated and purified by preparative HPLC to furnish the title compound, tert-butyl 3-amino-4,6-dimethyl-5-(2-morpholin-4-yl-ethoxy)-thieno[2,3-b]pyridine-2-carboxylate (20 mg, 30%).
Workup
- temperatureThe mixture was heated
- temperatureto reflux overnight
- customthe solvent was removed under reduced pressure, water
- additionwas added
- extractionthe residue was extracted with ethyl acetate (10 mL)
- washthe organic phases were washed with water (5 mL×3), brine
- dry with materialdried over anhydrous Na2SO4
- concentrationconcentrated
- custompurified by preparative HPLC
Sources & evidence
- ORD record
- ord-32a5e532dca24bbe9a93ad3ab3bf4a36
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07645881B2
Reaction notes
Loading…